Welcome to our company !

Call us now

08071794342

Rituximab Injection 500 Mg

Rituximab Injection 500 Mg

Product Details:

  • Packaging Type Glass vial, individually boxed
  • Indication Treatment of certain cancers and autoimmune diseases
  • Life Span 24 months from date of manufacture
  • Brand Name As per manufacturer (e.g., MabThera, Rituxan, or generic)
  • Dosage Form Injectable/Infusion
  • Pacakaging (Quantity Per Box) 1 vial per box
  • Salt Composition Rituximab
  • Click to View more
X

Rituximab Injection 500 Mg Price And Quantity

  • 100 Kit

Rituximab Injection 500 Mg Product Specifications

  • 500 mg/50 ml per vial
  • Biological/Monoclonal Antibody
  • Rituximab 500 mg
  • Treatment of certain cancers and autoimmune diseases
  • Glass vial, individually boxed
  • As per manufacturer (e.g., MabThera, Rituxan, or generic)
  • Monoclonal antibody for targeting CD20-positive B-cells
  • Injectable/Infusion
  • 24 months from date of manufacture
  • Administered via intravenous infusion under medical supervision. Dose varies by indication.
  • Rituximab
  • 1 vial per box
  • Adults
  • Imported or Indian origin, as per availability
  • As prescribed by physician
  • Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, and other autoimmune disorders as guided by clinician
  • Liquid, Solution for Infusion
  • Store at 2C - 8C. Do not freeze. Protect from light.
  • Cancer therapy, immunosuppressive therapy
  • Clear to slightly opalescent, colorless to pale yellow solution
  • ~145 kDa
  • Intravenous
  • As per manufacturer details
  • Prescription only
  • Infusion reactions, infections, cytopenias, cardiac events (refer to literature)
  • 10 mg/ml

Product Description

Rituximab injection is used alone or together with other medicines to treat a type of cancer called non-Hodgkin's lymphoma (NHL). It is also used in combination with other cancer medicines to treat mature B-cell non-Hodgkin's lymphoma (NHL) and mature B-cell acute leukemia (B-AL).

Powerful Treatment for Cancer and Autoimmune Disorders

Rituximab Injection 500 mg is renowned for its vital role in treating various malignant and autoimmune diseases. Acting as a targeted biological therapy, it reduces abnormal or overactive B-cells, thereby addressing the underlying cause of many of these conditions. Its application under clinician supervision helps ensure maximum benefit and safety.


Safe Administration and Proper Storage Guidelines

This injectable solution must be administered intravenously in a controlled medical setting to monitor for possible infusion reactions. For optimal stability and effectiveness, Rituximab must be stored at 2C-8C, kept away from light, and not frozen. Follow professional guidance for preparation and handling to maintain its integrity.

FAQ's of Rituximab Injection 500 Mg:


Q: How is Rituximab Injection 500 mg administered?

A: Rituximab Injection is given as an intravenous infusion under the direct supervision of a healthcare professional. The infusion is carefully administered in a clinical setting to monitor for any infusion-related reactions or adverse effects.

Q: What conditions is Rituximab Injection 500 mg commonly used to treat?

A: This medication is primarily indicated for treating Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, certain autoimmune disorders such as Rheumatoid Arthritis, and other CD20-positive B-cell diseases as directed by a clinician.

Q: When should Rituximab infusion be scheduled?

A: Rituximab infusions are scheduled as per the treating physician's protocol, based on the diagnosis and the patient's individual treatment plan. The frequency and number of infusions vary depending on the indication and the patient's response.

Q: Where should Rituximab Injection be stored before use?

A: The vials must be stored between 2C-8C in their original packaging, protected from light, and must not be frozen. Proper storage ensures the medication's stability and efficacy at the time of administration.

Q: What are the main benefits of Rituximab therapy?

A: Rituximab targets CD20-positive B-cells, offering effective treatment for certain cancers and autoimmune diseases. Its use can help control disease progression, reduce symptoms, and improve patient outcomes in eligible populations.

Q: What process should be followed before and during Rituximab infusion?

A: Before starting Rituximab, patients are assessed for contraindications and may receive premedication to reduce infusion reactions. During the infusion, vital signs and patient response are closely monitored, with medical staff prepared to address any adverse effects.

Q: What adverse effects should patients be aware of when using Rituximab?

A: Common adverse effects include infusion reactions, increased risk of infections, cytopenias (blood count changes), and possible cardiac events. Patients should promptly report any symptoms to their healthcare provider during or after infusion.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Injection' category



Back to top